CN1665406A - 饮料组合物和组合饮料的方法 - Google Patents
饮料组合物和组合饮料的方法 Download PDFInfo
- Publication number
- CN1665406A CN1665406A CN038157136A CN03815713A CN1665406A CN 1665406 A CN1665406 A CN 1665406A CN 038157136 A CN038157136 A CN 038157136A CN 03815713 A CN03815713 A CN 03815713A CN 1665406 A CN1665406 A CN 1665406A
- Authority
- CN
- China
- Prior art keywords
- activating agent
- beverage composition
- dental erosion
- treating dental
- user
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 91
- 238000000034 method Methods 0.000 title claims abstract description 32
- 230000000694 effects Effects 0.000 claims abstract description 42
- 239000000284 extract Substances 0.000 claims abstract description 37
- 229920002770 condensed tannin Polymers 0.000 claims abstract description 27
- 235000018192 pine bark supplement Nutrition 0.000 claims abstract description 27
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 23
- 239000008103 glucose Substances 0.000 claims abstract description 23
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 15
- 229930091371 Fructose Natural products 0.000 claims abstract description 14
- 239000005715 Fructose Substances 0.000 claims abstract description 14
- 235000000556 Paullinia cupana Nutrition 0.000 claims abstract description 10
- 240000003444 Paullinia cupana Species 0.000 claims abstract description 10
- 239000013543 active substance Substances 0.000 claims abstract description 10
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 9
- 235000013361 beverage Nutrition 0.000 claims description 76
- 239000003795 chemical substances by application Substances 0.000 claims description 59
- 230000003628 erosive effect Effects 0.000 claims description 57
- 230000003213 activating effect Effects 0.000 claims description 50
- 108090000623 proteins and genes Proteins 0.000 claims description 32
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 29
- 230000036541 health Effects 0.000 claims description 29
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 28
- 229930003935 flavonoid Natural products 0.000 claims description 25
- 150000002215 flavonoids Chemical class 0.000 claims description 25
- 235000017173 flavonoids Nutrition 0.000 claims description 25
- 235000016709 nutrition Nutrition 0.000 claims description 20
- 239000008280 blood Substances 0.000 claims description 18
- 210000004369 blood Anatomy 0.000 claims description 18
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 18
- 210000003205 muscle Anatomy 0.000 claims description 17
- 230000035764 nutrition Effects 0.000 claims description 17
- 239000003814 drug Substances 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 15
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 14
- 229960001948 caffeine Drugs 0.000 claims description 14
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 13
- 235000015097 nutrients Nutrition 0.000 claims description 12
- 230000003078 antioxidant effect Effects 0.000 claims description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical group OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 10
- 229940094952 green tea extract Drugs 0.000 claims description 10
- 235000020688 green tea extract Nutrition 0.000 claims description 10
- 239000011777 magnesium Substances 0.000 claims description 10
- 229910052749 magnesium Inorganic materials 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 229960003080 taurine Drugs 0.000 claims description 10
- 241000196324 Embryophyta Species 0.000 claims description 9
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 9
- 239000003963 antioxidant agent Substances 0.000 claims description 7
- 235000006708 antioxidants Nutrition 0.000 claims description 7
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 6
- 150000001720 carbohydrates Chemical class 0.000 claims description 6
- 235000014633 carbohydrates Nutrition 0.000 claims description 6
- 230000006378 damage Effects 0.000 claims description 6
- 229960000367 inositol Drugs 0.000 claims description 6
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 6
- 230000007774 longterm Effects 0.000 claims description 6
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 6
- 235000002639 sodium chloride Nutrition 0.000 claims description 6
- 229940088594 vitamin Drugs 0.000 claims description 6
- 229930003231 vitamin Natural products 0.000 claims description 6
- 235000013343 vitamin Nutrition 0.000 claims description 6
- 239000011782 vitamin Substances 0.000 claims description 6
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 5
- 206010020751 Hypersensitivity Diseases 0.000 claims description 5
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 125000001931 aliphatic group Chemical group 0.000 claims description 5
- 208000026935 allergic disease Diseases 0.000 claims description 5
- 230000007815 allergy Effects 0.000 claims description 5
- 229940024606 amino acid Drugs 0.000 claims description 5
- 235000001014 amino acid Nutrition 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 235000019136 lipoic acid Nutrition 0.000 claims description 5
- 239000011591 potassium Substances 0.000 claims description 5
- 229910052700 potassium Inorganic materials 0.000 claims description 5
- 239000006041 probiotic Substances 0.000 claims description 5
- 235000018291 probiotics Nutrition 0.000 claims description 5
- 229960002663 thioctic acid Drugs 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims description 4
- 108010087806 Carnosine Proteins 0.000 claims description 4
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 4
- 235000003713 Rhodiola rosea Nutrition 0.000 claims description 4
- 244000042430 Rhodiola rosea Species 0.000 claims description 4
- 229940044199 carnosine Drugs 0.000 claims description 4
- 229960001231 choline Drugs 0.000 claims description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 4
- 239000011651 chromium Substances 0.000 claims description 4
- 229910052804 chromium Inorganic materials 0.000 claims description 4
- 230000001627 detrimental effect Effects 0.000 claims description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 4
- 229930013686 lignan Natural products 0.000 claims description 4
- 235000009408 lignans Nutrition 0.000 claims description 4
- 150000005692 lignans Chemical class 0.000 claims description 4
- 239000011159 matrix material Substances 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 3
- 241000320316 Carduus Species 0.000 claims description 3
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 3
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 3
- 241001632410 Eleutherococcus senticosus Species 0.000 claims description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 3
- 235000009392 Vitis Nutrition 0.000 claims description 3
- 241000219095 Vitis Species 0.000 claims description 3
- 210000001367 artery Anatomy 0.000 claims description 3
- 235000021466 carotenoid Nutrition 0.000 claims description 3
- 150000001747 carotenoids Chemical class 0.000 claims description 3
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 3
- 230000000295 complement effect Effects 0.000 claims description 3
- 235000003373 curcuma longa Nutrition 0.000 claims description 3
- 239000007938 effervescent tablet Substances 0.000 claims description 3
- 239000000835 fiber Substances 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 229930013032 isoflavonoid Natural products 0.000 claims description 3
- 150000003817 isoflavonoid derivatives Chemical class 0.000 claims description 3
- 235000012891 isoflavonoids Nutrition 0.000 claims description 3
- 235000010755 mineral Nutrition 0.000 claims description 3
- 230000001537 neural effect Effects 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 235000018102 proteins Nutrition 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 3
- 235000013619 trace mineral Nutrition 0.000 claims description 3
- 239000011573 trace mineral Substances 0.000 claims description 3
- 235000013976 turmeric Nutrition 0.000 claims description 3
- 239000000341 volatile oil Substances 0.000 claims description 3
- 241000522254 Cassia Species 0.000 claims description 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims description 2
- 240000006927 Foeniculum vulgare Species 0.000 claims description 2
- 235000004204 Foeniculum vulgare Nutrition 0.000 claims description 2
- 235000011201 Ginkgo Nutrition 0.000 claims description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 2
- 244000194101 Ginkgo biloba Species 0.000 claims description 2
- 235000008694 Humulus lupulus Nutrition 0.000 claims description 2
- 235000010654 Melissa officinalis Nutrition 0.000 claims description 2
- 244000062730 Melissa officinalis Species 0.000 claims description 2
- 235000016357 Mirtillo rosso Nutrition 0.000 claims description 2
- 235000009421 Myristica fragrans Nutrition 0.000 claims description 2
- 244000270834 Myristica fragrans Species 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims description 2
- 235000007164 Oryza sativa Nutrition 0.000 claims description 2
- 235000011922 Passiflora incarnata Nutrition 0.000 claims description 2
- 240000008440 Passiflora incarnata Species 0.000 claims description 2
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims description 2
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 claims description 2
- 244000077923 Vaccinium vitis idaea Species 0.000 claims description 2
- 229930003270 Vitamin B Chemical group 0.000 claims description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 claims description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 2
- 229940014062 garlic preparation Drugs 0.000 claims description 2
- 210000004907 gland Anatomy 0.000 claims description 2
- 235000008216 herbs Nutrition 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 239000001702 nutmeg Substances 0.000 claims description 2
- 239000000419 plant extract Substances 0.000 claims description 2
- 230000000529 probiotic effect Effects 0.000 claims description 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 claims description 2
- 235000009566 rice Nutrition 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 229940035936 ubiquinone Drugs 0.000 claims description 2
- 210000003462 vein Anatomy 0.000 claims description 2
- 235000019156 vitamin B Nutrition 0.000 claims description 2
- 239000011720 vitamin B Chemical group 0.000 claims description 2
- 239000002023 wood Substances 0.000 claims description 2
- 244000163122 Curcuma domestica Species 0.000 claims 1
- 241001426396 Rhaponticum carthamoides Species 0.000 claims 1
- 244000291414 Vaccinium oxycoccus Species 0.000 claims 1
- 229940106796 pycnogenol Drugs 0.000 abstract description 24
- 230000009471 action Effects 0.000 abstract description 7
- 230000005923 long-lasting effect Effects 0.000 abstract 1
- 230000008859 change Effects 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 206010020772 Hypertension Diseases 0.000 description 9
- 244000078534 Vaccinium myrtillus Species 0.000 description 9
- 230000009286 beneficial effect Effects 0.000 description 9
- 229960004203 carnitine Drugs 0.000 description 9
- 230000004087 circulation Effects 0.000 description 9
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 230000004060 metabolic process Effects 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 235000008504 concentrate Nutrition 0.000 description 8
- 235000019152 folic acid Nutrition 0.000 description 8
- 239000011724 folic acid Substances 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 244000269722 Thea sinensis Species 0.000 description 7
- 239000012141 concentrate Substances 0.000 description 7
- 229940014144 folate Drugs 0.000 description 7
- 230000035882 stress Effects 0.000 description 7
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 235000009569 green tea Nutrition 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 5
- 235000011613 Pinus brutia Nutrition 0.000 description 5
- 241000018646 Pinus brutia Species 0.000 description 5
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 5
- 210000003022 colostrum Anatomy 0.000 description 5
- 235000021277 colostrum Nutrition 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 239000005556 hormone Substances 0.000 description 5
- 229940088597 hormone Drugs 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 235000020733 paullinia cupana extract Nutrition 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- 235000017848 Rubus fruticosus Nutrition 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 4
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 4
- 235000021029 blackberry Nutrition 0.000 description 4
- 235000021014 blueberries Nutrition 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 210000000748 cardiovascular system Anatomy 0.000 description 4
- 238000009795 derivation Methods 0.000 description 4
- 235000015897 energy drink Nutrition 0.000 description 4
- 229930195712 glutamate Natural products 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 229940098465 tincture Drugs 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 230000008485 antagonism Effects 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 235000021028 berry Nutrition 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000023852 carbohydrate metabolic process Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 239000002417 nutraceutical Substances 0.000 description 3
- 235000021436 nutraceutical agent Nutrition 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 description 3
- PHIQHXFUZVPYII-LURJTMIESA-N (S)-carnitine Chemical compound C[N+](C)(C)C[C@@H](O)CC([O-])=O PHIQHXFUZVPYII-LURJTMIESA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 241000218631 Coniferophyta Species 0.000 description 2
- 244000008991 Curcuma longa Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000005954 Methylenetetrahydrofolate Reductase (NADPH2) Human genes 0.000 description 2
- 108010030837 Methylenetetrahydrofolate Reductase (NADPH2) Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 235000005205 Pinus Nutrition 0.000 description 2
- 241000218602 Pinus <genus> Species 0.000 description 2
- 241001426527 Rhaponticum Species 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- LKDRXBCSQODPBY-ZXXMMSQZSA-N alpha-D-fructopyranose Chemical compound OC[C@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-ZXXMMSQZSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000000386 athletic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 2
- 150000002216 flavonol derivatives Chemical class 0.000 description 2
- 235000011957 flavonols Nutrition 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 230000002641 glycemic effect Effects 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000019710 soybean protein Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- RFWGABANNQMHMZ-UHFFFAOYSA-N 8-acetoxy-7-acetyl-6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4',5':4,5]benzo[1,2,3-de]quinoline Natural products CC=C1C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O RFWGABANNQMHMZ-UHFFFAOYSA-N 0.000 description 1
- 240000005020 Acaciella glauca Species 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 102000005862 Angiotensin II Human genes 0.000 description 1
- 101800000733 Angiotensin-2 Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003402 Arthropod sting Diseases 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 235000004035 Cryptotaenia japonica Nutrition 0.000 description 1
- 101800005209 Deltorphin Proteins 0.000 description 1
- BHSURCCZOBVHJJ-NWOHMYAQSA-N Deltorphin A Chemical compound C([C@H](N)C(=O)N[C@H](CCSC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(N)=O)C1=CC=C(O)C=C1 BHSURCCZOBVHJJ-NWOHMYAQSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- HKVGJQVJNQRJPO-UHFFFAOYSA-N Demethyloleuropein Natural products O1C=C(C(O)=O)C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(=CC)C1OC1OC(CO)C(O)C(O)C1O HKVGJQVJNQRJPO-UHFFFAOYSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 235000001950 Elaeis guineensis Nutrition 0.000 description 1
- 244000127993 Elaeis melanococca Species 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- 235000021559 Fruit Juice Concentrate Nutrition 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 235000013628 Lantana involucrata Nutrition 0.000 description 1
- 240000005183 Lantana involucrata Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- 102000003797 Neuropeptides Human genes 0.000 description 1
- RFWGABANNQMHMZ-HYYSZPHDSA-N Oleuropein Chemical compound O([C@@H]1OC=C([C@H](C1=CC)CC(=O)OCCC=1C=C(O)C(O)=CC=1)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RFWGABANNQMHMZ-HYYSZPHDSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000364051 Pima Species 0.000 description 1
- 235000008582 Pinus sylvestris Nutrition 0.000 description 1
- 244000143590 Salvia chinensis Species 0.000 description 1
- 235000007154 Salvia chinensis Nutrition 0.000 description 1
- 235000005794 Salvia japonica Nutrition 0.000 description 1
- 241000030538 Thecla Species 0.000 description 1
- 102000007641 Trefoil Factors Human genes 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 235000015724 Trifolium pratense Nutrition 0.000 description 1
- 241000736767 Vaccinium Species 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 230000036626 alertness Effects 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940124325 anabolic agent Drugs 0.000 description 1
- 239000003263 anabolic agent Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229950006323 angiotensin ii Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000036995 brain health Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 238000003869 coulometry Methods 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000001834 epinephrinelike Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000002206 flavan-3-ols Chemical class 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 150000002208 flavanones Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005908 glyceryl ester group Chemical group 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- -1 hydroxyl radical free radical Chemical class 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 235000020667 long-chain omega-3 fatty acid Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000012067 mathematical method Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- RFWGABANNQMHMZ-CARRXEGNSA-N oleuropein Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)C(=CC)[C@H]1CC(=O)OCCc3ccc(O)c(O)c3 RFWGABANNQMHMZ-CARRXEGNSA-N 0.000 description 1
- 235000011576 oleuropein Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000001839 pinus sylvestris Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- SGDJFCRVZKJZCO-VRUIMAEFSA-L potassium;sodium;(2e,4e)-hexa-2,4-dienoate;benzoate Chemical compound [Na+].[K+].C\C=C\C=C\C([O-])=O.[O-]C(=O)C1=CC=CC=C1 SGDJFCRVZKJZCO-VRUIMAEFSA-L 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000011265 semifinished product Substances 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- 235000017700 silymarin Nutrition 0.000 description 1
- 229960004245 silymarin Drugs 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000002438 stress hormone Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
Description
1kg浓缩物(将以1∶10被稀释) | 500ml部分(供引用) | 含量,100g饮料中 | |
成分水I水II果糖葡萄糖苹果浓缩物70%柠檬浓缩物B×67.65Lignon浓缩物65%瓜拉那提取物牛磺酸Pycnogenol | g435.2780.00296.0074.0040.002.515.007.005.000.50 | 部分mg/500ml21763.54000148003700200012575035025025 | %重量份4.350.802.960.740.400.0250.150.070.050.005 |
咖啡因绿茶提取物4∶1L-肉碱UPS 100%肌醇柠檬酸三镁KCl(K 52%)NaCl(Na 39%)苯甲酸钠山梨酸钾Ginkgomax酊剂Relaxor酊剂Avenamax酊剂Dynaforce | 0.131.0010.000.3025.804.02.00.501.0010.00ml4.0ml5.0ml10.0ml | 6.55050015129020010025500.5ml0.20ml0.25ml0.5ml | 0.00130.010.100.0020.2580.040.020.0050.010.10(大约0.04(大约)0.05(大约)0.10(大约) |
Claims (25)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20021031 | 2002-05-31 | ||
FI20021031A FI20021031A (fi) | 2001-12-28 | 2002-05-31 | Ravintoautomaatti |
FI20021034 | 2002-05-31 | ||
FI20021034A FI20021034A (fi) | 2002-05-31 | 2002-05-31 | Juomakoostumus |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1665406A true CN1665406A (zh) | 2005-09-07 |
CN100553499C CN100553499C (zh) | 2009-10-28 |
Family
ID=29713335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB038157136A Expired - Fee Related CN100553499C (zh) | 2002-05-31 | 2003-06-02 | 饮料组合物和组合饮料的方法 |
Country Status (9)
Country | Link |
---|---|
US (1) | US7638148B2 (zh) |
EP (1) | EP1551239B1 (zh) |
JP (1) | JP2005527234A (zh) |
CN (1) | CN100553499C (zh) |
AT (1) | ATE520317T1 (zh) |
AU (1) | AU2003233835A1 (zh) |
CA (1) | CA2487588C (zh) |
HK (1) | HK1080337A1 (zh) |
WO (1) | WO2003101225A1 (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102100805A (zh) * | 2011-01-31 | 2011-06-22 | 上海东锦食品集团有限公司 | 一种具有缓解体力疲劳及增强免疫功能的组合物及其制备方法和用途 |
CN102150859A (zh) * | 2011-01-31 | 2011-08-17 | 上海东锦食品集团有限公司 | 一种具有缓解体力疲劳及改善记忆功能的组合物及其制备方法和用途 |
CN101433314B (zh) * | 2007-11-13 | 2012-05-30 | 蒋爱芳 | 一种具有抗疲劳、抗氧化功能的保健食品 |
CN102845795A (zh) * | 2012-09-21 | 2013-01-02 | 北京市百利然科技开发有限公司 | 一种功能性保健饮料 |
CN102048214B (zh) * | 2009-10-27 | 2013-04-03 | 吕学栋 | 复方硫辛酸饮料 |
CN106999455A (zh) * | 2014-12-16 | 2017-08-01 | 边钟贤 | 改性牛磺酸以及含有改性牛磺酸的用于预防或治疗代谢疾病的药物组合物 |
CN109198090A (zh) * | 2018-09-27 | 2019-01-15 | 芜湖市好亦快食品有限公司三山分公司 | 藻油dha液体饮料及其制备方法 |
CN109476590A (zh) * | 2016-06-15 | 2019-03-15 | 边钟贤 | 改性牛磺酸及其制备方法 |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060021383A (ko) * | 2003-06-19 | 2006-03-07 | 산또리 가부시키가이샤 | 운동 생리 기능 향상제 |
GB0316550D0 (en) * | 2003-07-15 | 2003-08-20 | Forum Bioscience Holdings Ltd | Sucrose substitute |
JP2005047839A (ja) * | 2003-07-31 | 2005-02-24 | Toyo Shinyaku:Kk | プロアントシアニジン含有組成物 |
JP2005185188A (ja) * | 2003-12-25 | 2005-07-14 | Nichirei Corp | アセロラ処理物およびl−カルニチン含有組成物 |
US7785640B2 (en) | 2004-01-16 | 2010-08-31 | Amerilab Technologies, Inc. | Effervescent composition including cranberry extract |
EP1600061B1 (en) * | 2004-05-25 | 2010-05-12 | Cognis IP Management GmbH | Oral and/or topical compositions |
DE102004060314A1 (de) * | 2004-12-08 | 2006-08-31 | Beiersdorf Ag | Wirkstoffkombinationen aus einem oder mehreren Isoflavonoiden und Carnitin und/oder einem oder mehreren Acyl-Carnitinen |
US20090186127A1 (en) * | 2004-12-15 | 2009-07-23 | Krumhar Kim C | Energy drink compositions |
DE102005006241A1 (de) * | 2005-02-10 | 2006-08-17 | Patrick Faber | Verwendung von Tryptophan, Nahrungsmittel und Getränk |
MY162337A (en) | 2005-05-02 | 2017-06-15 | 4Life Res Llc | Transfer factor preparations and associated methods |
US9028882B2 (en) | 2005-05-02 | 2015-05-12 | 4Life Patents, Llc | Nutraceutical gels |
US20090087495A1 (en) * | 2005-05-19 | 2009-04-02 | Nippon Meat Packers, Inc. | Food for Improving Motor Function |
EP1921929A4 (en) * | 2005-08-12 | 2009-08-05 | Multi Formulations Ltd | ADDITIVE FOOD PRODUCT CONTAINING CAFFEINE, TAURIN AND GINSENG |
JP4635159B2 (ja) * | 2005-09-05 | 2011-02-16 | 独立行政法人農業・食品産業技術総合研究機構 | Gabaを高濃度に含有する食用植物体及びその製造方法 |
JP4868619B2 (ja) * | 2005-09-05 | 2012-02-01 | 独立行政法人農業・食品産業技術総合研究機構 | ビタミンU、タウリン、カルノシン、Tyr−Proおよび/またはL−カルニチンを高濃度に含有する食用植物体及びその製造方法 |
JP4840003B2 (ja) * | 2006-07-20 | 2011-12-21 | 大正製薬株式会社 | 経口用組成物 |
ITMI20061854A1 (it) * | 2006-09-28 | 2008-03-29 | Genalta S R L | Bevanda atta a rallentare la degenerazione cellulare che accompagna l'invecchiamento |
US8246961B2 (en) * | 2007-02-06 | 2012-08-21 | Fujifilm Corporation | Powder composition, method for producing the same, and food composition, cosmetic composition and pharmaceutical composition containing the same |
GB0704566D0 (en) * | 2007-03-08 | 2007-04-18 | Leigh Steven | Nutrient compositions |
GB2450076B (en) * | 2007-05-17 | 2012-09-26 | Sis Science In Sport Ltd | Nutritional composition |
ES2325845B1 (es) * | 2007-10-05 | 2010-07-06 | Vicente Segovia Parra | Neutralizador natural para el ansia de comer. |
US8187647B2 (en) | 2008-06-13 | 2012-05-29 | BioClinical Development, Inc. | Edible energy composition |
ES2716226T3 (es) * | 2007-11-16 | 2019-06-11 | Int Ip Holdings Llc | Composición energética comestible con un contenido bajo en cafeína |
DE202007016949U1 (de) | 2007-12-05 | 2009-01-08 | Weinhaus Dr. Kling Ag | Weingetränk mit Anregungsstoffen |
US20090226572A1 (en) * | 2008-03-10 | 2009-09-10 | Leonid Danushevsky | Edible containers having beneficial gas |
US9049879B2 (en) | 2008-06-13 | 2015-06-09 | International Ip Holdings Llc | Edible energy composition |
US10881661B2 (en) | 2008-06-13 | 2021-01-05 | International Ip Holdings Llc | Edible energy composition |
WO2010019255A1 (en) * | 2008-08-13 | 2010-02-18 | Virun, Inc. | Compositions containing aminoalkanes and aminoalkane derivatives |
US20110300175A1 (en) * | 2008-10-03 | 2011-12-08 | Sigma Alimentos, S.A. De C.V. | Composition for promoting control of total and ldl cholesterol, and/or weight loss and/or thermogenesis |
US10980244B2 (en) | 2008-11-04 | 2021-04-20 | The Quaker Oats Company | Whole grain composition comprising hydrolyzed starch |
US10689678B2 (en) | 2008-11-04 | 2020-06-23 | The Quaker Oats Company | Method and composition comprising hydrolyzed starch |
US9622500B2 (en) | 2008-11-04 | 2017-04-18 | The Quaker Oats Company | Food products prepared with soluble whole grain oat flour |
US9504272B2 (en) | 2008-11-04 | 2016-11-29 | The Quaker Oats Company | Method of processing oats to achieve oats with an increased avenanthramide content |
US9510614B2 (en) | 2008-11-04 | 2016-12-06 | The Quaker Oats Company | Food products prepared with soluble whole grain oat flour |
FR2945445B1 (fr) * | 2009-05-13 | 2012-12-14 | Oreal | Utilisation pour le maintien et/ou la fixation des fibres keratiniques d'une composition comprenant au moins un polyphenol et au moins un sucre. |
US20110104311A1 (en) * | 2009-10-30 | 2011-05-05 | John Ronald Dooley | Performance Beverage |
WO2011056174A1 (en) * | 2009-11-05 | 2011-05-12 | Govindan Gopinathan | Migraine headache relief composition |
US9180078B2 (en) * | 2010-06-08 | 2015-11-10 | Beijing Gingko Group Biological Technology Co. | Cosmetic composition containing lingonberry extract and its uses |
US20130171278A1 (en) * | 2010-09-17 | 2013-07-04 | Korea Food Research Institute | Composition for promoting memory and learning ability |
EP2632474B1 (en) * | 2010-10-26 | 2016-08-24 | Vasil Petrov Terezov | Composition for food supplement and its use for lowering high cholesterol level |
MY181245A (en) | 2011-03-21 | 2020-12-21 | Pepsico Inc | Method for preparing high acid rtd whole grain beverages |
ITGE20110050A1 (it) * | 2011-04-29 | 2012-10-30 | Marco Zipoli | Alimento, in particolare una bevanda per l'alimentazione umana |
JP2012250940A (ja) * | 2011-06-03 | 2012-12-20 | Kumamoto Univ | C型肝炎の予防、治療又は改善用組成物 |
NZ619634A (en) * | 2011-07-08 | 2016-05-27 | Peter Lehrke | Therapeutic composition and uses thereof |
MX358952B (es) | 2011-07-12 | 2018-09-10 | Pepsico Inc | Método para preparar una bebida láctea que contiene avena. |
KR101341162B1 (ko) | 2011-11-30 | 2014-01-06 | 농업회사법인 주식회사 임형문꿀연구소 | 소나무 피 추출액을 이용한 음료 첨가물 및 그 제조방법 |
IL226913B (en) | 2012-06-13 | 2020-01-30 | Inno Bev Ltd | Preparations containing natural extracts |
JP2014064505A (ja) * | 2012-09-25 | 2014-04-17 | Fujifilm Corp | 食品用組成物および脂質吸収抑制剤 |
KR101429673B1 (ko) * | 2012-12-20 | 2014-08-13 | 건양대학교산학협력단 | 발효 홍삼을 이용한 발포정 및 그 제조방법 |
RU2525253C1 (ru) * | 2013-02-15 | 2014-08-10 | Закрытое акционерное общество "Управляющая компания "Висма" | Безалкогольный тонизирующий напиток (мега вита) газированный |
US9604765B2 (en) | 2013-03-14 | 2017-03-28 | Ahhmigo, Llc | Locking cap device and methods |
US9351517B2 (en) | 2013-03-15 | 2016-05-31 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and compositions containing same |
AT13704U1 (de) * | 2013-04-03 | 2014-07-15 | Alp Vital Ltd | Teegetränk |
EP2813233B1 (en) | 2013-06-13 | 2018-08-15 | Inno-Bev Ltd. | Composition comprising natural extracts |
US9861611B2 (en) | 2014-09-18 | 2018-01-09 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same |
US10016363B2 (en) | 2014-09-18 | 2018-07-10 | Virun, Inc. | Pre-spray emulsions and powders containing non-polar compounds |
EP3215990A4 (en) * | 2014-11-03 | 2018-04-11 | Myaveta LLC | Systems and methods for formulating customized beverages |
US20170275662A1 (en) | 2016-03-22 | 2017-09-28 | The Quaker Oats Company | Method and Apparatus for Controlled Hydrolysis |
US11172695B2 (en) | 2016-03-22 | 2021-11-16 | The Quaker Oats Company | Method, apparatus, and product providing hydrolyzed starch and fiber |
FR3056381B1 (fr) * | 2016-09-26 | 2019-11-15 | Futur Optimal | Composition comprenant de la carnosine |
US20210227855A1 (en) * | 2018-06-23 | 2021-07-29 | Seattle Gummy Company | Methods and compositions for reducing caffeine side effects |
US11424019B2 (en) * | 2020-01-22 | 2022-08-23 | Rockspoon, Inc. | System and methods for personal food item customization |
US20220030923A1 (en) * | 2020-07-17 | 2022-02-03 | Northern Innovations Holding Corp. | Caffeine and Alpha Lipoic Acid Compositions for Enhanced Sensory Effects |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4698360B1 (en) | 1985-04-09 | 1997-11-04 | D Investigations Pharmacologiq | Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof |
US4946701A (en) | 1989-08-04 | 1990-08-07 | Procter & Gamble | Beverages |
US6024281A (en) | 1989-09-27 | 2000-02-15 | Shepley; Kenneth James | Nutritional information system for shoppers |
US5233520A (en) | 1990-12-19 | 1993-08-03 | The United States Of America As Represented By The Secretary Of Agriculture | Method and system for measurement of intake of foods, nutrients and other food components in the diet |
US5412564A (en) | 1994-02-03 | 1995-05-02 | Ecer; Gunes M. | System and method for diet control |
US5704350A (en) | 1994-03-25 | 1998-01-06 | Nutritec Corporation | Nutritional microcomputer and method |
DE19611827A1 (de) * | 1996-03-26 | 1998-01-08 | Michael Otto | Erfrischungs-(Misch)getränk mit nachfolgend aufgeführten wesentlichen Inhaltsstoffen, Taurin, Coffein oder Guarana, Kohlensäure, Alkohol unter 15% vol. |
US6224872B1 (en) | 1997-07-31 | 2001-05-01 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Composition |
US5972985A (en) * | 1997-11-03 | 1999-10-26 | Cytos Pharmaceuticals, Llc | Histidine containing nutriceutical compositions |
JPH11318402A (ja) * | 1998-05-11 | 1999-11-24 | Kikkoman Corp | 抗疲労ドリンク剤 |
AU4217499A (en) * | 1998-05-29 | 1999-12-13 | Adams Food Ltd. | Composition having therapeutic and/or nutritionally active substituent |
US6358546B1 (en) | 1999-01-15 | 2002-03-19 | Ralston Purina Company | Methods for customizing pet food |
US6413558B1 (en) | 1999-07-19 | 2002-07-02 | The Proctor & Gamble Co. | Compositions, kits, and methods for providing and maintaining energy and metal alertness |
DE19937079A1 (de) | 1999-08-06 | 2001-02-08 | Vitafood Ag St Gallen | Energiegetränk |
-
2003
- 2003-06-02 AU AU2003233835A patent/AU2003233835A1/en not_active Abandoned
- 2003-06-02 CA CA2487588A patent/CA2487588C/en not_active Expired - Fee Related
- 2003-06-02 WO PCT/FI2003/000437 patent/WO2003101225A1/en active Application Filing
- 2003-06-02 EP EP03727547A patent/EP1551239B1/en not_active Expired - Lifetime
- 2003-06-02 AT AT03727547T patent/ATE520317T1/de not_active IP Right Cessation
- 2003-06-02 JP JP2004508594A patent/JP2005527234A/ja active Pending
- 2003-06-02 US US10/516,477 patent/US7638148B2/en not_active Expired - Fee Related
- 2003-06-02 CN CNB038157136A patent/CN100553499C/zh not_active Expired - Fee Related
-
2006
- 2006-01-10 HK HK06100403.5A patent/HK1080337A1/xx not_active IP Right Cessation
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101433314B (zh) * | 2007-11-13 | 2012-05-30 | 蒋爱芳 | 一种具有抗疲劳、抗氧化功能的保健食品 |
CN102048214B (zh) * | 2009-10-27 | 2013-04-03 | 吕学栋 | 复方硫辛酸饮料 |
CN102100805A (zh) * | 2011-01-31 | 2011-06-22 | 上海东锦食品集团有限公司 | 一种具有缓解体力疲劳及增强免疫功能的组合物及其制备方法和用途 |
CN102150859A (zh) * | 2011-01-31 | 2011-08-17 | 上海东锦食品集团有限公司 | 一种具有缓解体力疲劳及改善记忆功能的组合物及其制备方法和用途 |
CN102100805B (zh) * | 2011-01-31 | 2012-07-25 | 上海东锦食品集团有限公司 | 一种具有缓解体力疲劳及增强免疫功能的组合物及其制备方法和用途 |
CN102150859B (zh) * | 2011-01-31 | 2013-01-16 | 上海东锦食品集团有限公司 | 一种具有缓解体力疲劳及改善记忆功能的组合物及其制备方法和用途 |
CN102845795A (zh) * | 2012-09-21 | 2013-01-02 | 北京市百利然科技开发有限公司 | 一种功能性保健饮料 |
CN106999455A (zh) * | 2014-12-16 | 2017-08-01 | 边钟贤 | 改性牛磺酸以及含有改性牛磺酸的用于预防或治疗代谢疾病的药物组合物 |
CN109476590A (zh) * | 2016-06-15 | 2019-03-15 | 边钟贤 | 改性牛磺酸及其制备方法 |
CN109198090A (zh) * | 2018-09-27 | 2019-01-15 | 芜湖市好亦快食品有限公司三山分公司 | 藻油dha液体饮料及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
AU2003233835A1 (en) | 2003-12-19 |
HK1080337A1 (en) | 2006-04-28 |
US7638148B2 (en) | 2009-12-29 |
US20060134299A1 (en) | 2006-06-22 |
EP1551239B1 (en) | 2011-08-17 |
JP2005527234A (ja) | 2005-09-15 |
EP1551239A1 (en) | 2005-07-13 |
ATE520317T1 (de) | 2011-09-15 |
CN100553499C (zh) | 2009-10-28 |
CA2487588A1 (en) | 2003-12-11 |
CA2487588C (en) | 2011-09-27 |
WO2003101225A1 (en) | 2003-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100553499C (zh) | 饮料组合物和组合饮料的方法 | |
CN102106498A (zh) | 一种减肥代餐粉 | |
CN108651998A (zh) | 一种具有缓解疲劳功能的乳清蛋白粉及其制备方法 | |
CN104509919A (zh) | 一种功能性营养素饮料 | |
EP1982604A1 (de) | Nahrungsergänzungsmittel zum Ausgleich von Nährstoffmangel | |
CN101036519A (zh) | 一种营养粉及其制备方法 | |
CN106983854A (zh) | 用于苯丙酮尿症和其他代谢疾病的营养控制的糖巨肽药用食物 | |
CN101296693A (zh) | 持久力提高剂 | |
DE202012011540U1 (de) | Nahrungsmittelzusammensetzung mit Aminosäuren und Kakao | |
KR101488612B1 (ko) | 흑색 식품소재를 함유하는 건강식품 및 약학적 조성물 | |
Lokhande | Role of nutraceuticals in various diseases: A comprehensive review | |
Tirla et al. | New insight and future perspectives on nutraceuticals for improving sports performance of combat players: Focus on natural supplements, importance and advantages over synthetic ones | |
CN103238889B (zh) | 一种抗疲劳苹果醋保健饮料及其制备方法 | |
JP2006197911A (ja) | 蜂の子利用の健康食品。 | |
Bean | Sports Supplements: Which nutritional supplements really work | |
US20190373939A1 (en) | Methods of Making a Bigger Volume of Foods for Weight Control | |
Chauhan et al. | Effects of ergogenic supplements and dietary supplements on young athletes’ performance: A review | |
KR20090034803A (ko) | 근육 장애의 치료를 위한 잔톤 유도체 | |
Laganà et al. | Mediterranean diet, sport and health | |
CN1948451A (zh) | 一种保健酒及其制备方法 | |
Aljaloud | Dietary supplements for professional athletes: A great potential for Saudi Arabia | |
WO2023188173A1 (ja) | 脳内のgaba増加剤 | |
Qazi et al. | Nutraceuticals in sports medicine | |
KR20170014237A (ko) | 발효 흑마늘 및 흑양파가 포함된 젤리스틱 및 이의 제조방법 | |
CN106070794A (zh) | 一种清血保健茶及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: FLO BEVERAGE CO. Free format text: FORMER OWNER: SUOMEN RAVITSEMUSINST TI OY Effective date: 20111214 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20111214 Address after: Helsinki Patentee after: Flo Beverage Co Address before: Helsinki Patentee before: Suomen Ravitsemusinst Ti OY |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091028 Termination date: 20170602 |
|
CF01 | Termination of patent right due to non-payment of annual fee |